- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tiotropium placebo
Total 53673 results
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Finland, Germany, Netherlands
-
Boehringer IngelheimCompleted
-
Orion Corporation, Orion PharmaCompletedHealthy Volunteer | COPDEstonia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Verona Pharma plcIqvia Pty Ltd; LGC LimitedCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
Theravance BiopharmaViatris Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Austria, Canada, Germany, Netherlands, Russian Federation, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
Boehringer IngelheimPfizerCompleted
-
Boehringer IngelheimCompleted
-
Verona Pharma plcCompletedChronic Obstructive Pulmonary Disease Moderate
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
Virginia Commonwealth UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure With Normal Ejection FractionUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Bulgaria, Germany, Guatemala, Hungary, Israel, Latvia, Mexico, Philippines, Portugal, South Africa, Ukraine
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Germany, Latvia, Lithuania, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden
-
Novartis PharmaceuticalsCompletedCOPDGermany, Spain, United Kingdom, Italy
-
Boehringer IngelheimPfizerCompletedAsthmaArgentina, Austria, Croatia, Estonia, Guatemala, Hungary, India, Italy, Korea, Republic of, Latvia, Poland, Slovakia
-
Boehringer IngelheimPfizerCompletedAsthmaAustria, Czech Republic, Estonia, Germany, Latvia
-
McMaster UniversityBoehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Germany, Guatemala, Hungary, Latvia, Lithuania, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, South Africa, Sweden
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, Slovakia, Sweden
-
Teva Branded Pharmaceutical Products R&D, Inc.WithdrawnChronic Obstructive Pulmonary Disease | COPD
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Bulgaria, Canada, Germany, Guatemala, Hungary, Korea, Republic of, Latvia, Lithuania, Norway, Portugal, Romania, Russian Federation, Sweden, Ukraine, United Kingdom
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Chile, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Russian Federation, Slovakia, Spain, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Germany, Hungary
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Turkey, Ukraine, United...
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveNetherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveDenmark, Austria, Finland, France, Slovenia
-
Mel Shiuann-Sheng LeeNovartisCompletedFunctional Outcomes | Prevention of BMD Loss After THR | Serum Markers of Bone TurnoverTaiwan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Netherlands, Norway
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedCystic FibrosisUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, New Zealand, Portugal, Russian Federation, United Kingdom
-
Boehringer IngelheimCompleted
-
Imperial College LondonBoehringer IngelheimCompleted
-
Xiromed LLCLaboratorios Liconsa; ExeltisCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Denmark, Finland, France, Georgia, Germany, Greece, Guatemala, Hungary, India, Ireland, Israel, Italy, Korea, Republic of, Latvia, ... and more